IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 218 filers reported holding IMMUNOGEN INC in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,235,226 | -2.4% | 140,846 | +16.0% | 0.00% | 0.0% |
| Q2 2023 | $2,291,328 | +2279.8% | 121,427 | +384.3% | 0.00% | – |
| Q1 2023 | $96,284 | -21.7% | 25,074 | +1.1% | 0.00% | – |
| Q4 2022 | $123,003 | +3.4% | 24,799 | -0.0% | 0.00% | – |
| Q3 2022 | $119,000 | -8.5% | 24,810 | -13.9% | 0.00% | – |
| Q2 2022 | $130,000 | -8.5% | 28,812 | -1.7% | 0.00% | – |
| Q1 2022 | $142,000 | -34.0% | 29,319 | +1.2% | 0.00% | – |
| Q4 2021 | $215,000 | +34.4% | 28,985 | +2.7% | 0.00% | – |
| Q3 2021 | $160,000 | -12.6% | 28,235 | +1.8% | 0.00% | – |
| Q2 2021 | $183,000 | -25.0% | 27,725 | -8.1% | 0.00% | – |
| Q1 2021 | $244,000 | +29.8% | 30,171 | +3.3% | 0.00% | – |
| Q4 2020 | $188,000 | +102.2% | 29,216 | +13.2% | 0.00% | – |
| Q3 2020 | $93,000 | -25.6% | 25,805 | -5.4% | 0.00% | – |
| Q2 2020 | $125,000 | -35.6% | 27,272 | -51.9% | 0.00% | – |
| Q1 2020 | $194,000 | +5.4% | 56,736 | +57.0% | 0.00% | – |
| Q4 2019 | $184,000 | +201.6% | 36,129 | +44.3% | 0.00% | – |
| Q3 2019 | $61,000 | – | 25,037 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
| Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
| Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
| Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
| PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
| Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
| BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
| SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
| ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |